Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 2/2009

01-02-2009 | Letter to the Editor

Multiple myeloma presenting with spinal cord compression during pregnancy

Authors: John Quinn, Neil Rabin, Manuel Rodriguez-Justo, David Choi, Kwee Yong

Published in: Annals of Hematology | Issue 2/2009

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Smith A, Wisloff F, Samson D, UK Myeloma Forum et al (2006) Nordic Myeloma Study Group; British Committee for Standards in Haematology. Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol 132(4):410–451 FebPubMedCrossRef
2.
Zun KH, Choi HM (2008) Multiple myeloma presenting as vertebral compression during pregnancy. Int J Gynaecol Obstet 100(1):89–90 JanPubMedCrossRef
3.
Greig PC, Murtha AP, Jimmerson CJ et al (1997) Maternal serum interleukin-6 during pregnancy and during term and preterm labor. Obstet Gynecol 90(3):465–469 SepPubMedCrossRef
4.
Gargosky SE, Moyse KJ, Walton PE et al (1990) Circulating levels of insulin-like growth factors increase and molecular forms of their serum binding proteins change with human pregnancy. Biochem Biophys Res Commun 170(3):1157–1163 Aug 16PubMedCrossRef
Metadata
Title
Multiple myeloma presenting with spinal cord compression during pregnancy
Authors
John Quinn
Neil Rabin
Manuel Rodriguez-Justo
David Choi
Kwee Yong
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 2/2009
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-008-0558-9

Other articles of this Issue 2/2009

Annals of Hematology 2/2009 Go to the issue

Letter to the Editor

Hepatotoxicity as a rare but serious side effect of Thalidomide

Original Article

Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab

Original Article

Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma

Letter to the Editor

Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone

Original Article

Clinical features and prognostic factors of patients with “peripheral T cell lymphoma, unspecified”

Original Article

Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits